PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CNIO researchers propose a new combined therapy to treat cancer

The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments

2014-02-06
(Press-News.org) Contact information: Nuria Noriega
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
CNIO researchers propose a new combined therapy to treat cancer The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments

A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs—many of which have already been introduced into clinical practice—that permit higher overall survival rates and improvements in the quality of life of cancer patients.

Marcos Malumbres, a researcher at the Spanish National Cancer Research Centre (CNIO), and his team have discovered how etoposide — a drug widely used in the treatment of lung and testicular cancers, leukaemias and brain tumours — could increase its efficiency and specificity in combination with other compounds that interfere with cell division. The results are published today in the journal Cell Reports.

The study has been carried out jointly with the Groups of Óscar Fernández-Capetillo and Javier Muñoz's at the CNIO, and with Hiroyuki Yamano's team at the University College London's Cancer Institute.

Etoposide, a compound obtained from a variant of the mandrake plant, blocks a protein needed for DNA repair during cell division: the Topoisomerase II (TOP2) enzyme. This blocking action increases the damage to genetic material and causes cell death.

Malumbres explains that: "Etoposide affects tumour cells, which are the ones that divide the most and that need TOP2 to repair their DNA, but it also affects healthy cells", adding that: "this lack of specificity causes alterations in healthy tissues that translate into secondary illnesses and toxicity for the organism".

The researchers point out that "the challenge now is to improve the drug's therapeutic window, so that the dose range becomes more effective without increasing toxicity and the secondary effects associated with the treatment".

TREATMENTS TARGETING TUMOUR CELLS

Up until now, data on molecular pathways that govern topoisomerase levels in cells were scarce and did not clarify much. Now, Manuel Eguren, a researcher on Malumbres's team, has, for the first time in animal models and in human cell lines, related TOP2 with the cell division protein regulator Cdh1, so that a decrease in Cdh1 activity increases TOP2 levels in cells.

This study allows for the identification of the formula for increasing TOP2 levels in cells. The research team therefore proposes a new form of effective tumour treatment: the combination of Cdh1 inhibitors (amongst which can be found a substance called proTAME) with etoposide.

"proTAME — which is undergoing preclinical trials to inhibit tumour cell division — could increase the effectiveness of etoposide in cancer cells, those that divide the most and those that therefore have a greater dependency on TOP2 to maintain DNA integrity", say the researchers. This combination of drugs could maximise the anti-neoplastic effect of etoposide and would imply a reduction in the dose and lower toxicity.

Previous studies further indicate that Cdh1 is inactive in some patients due to various oncogenic mutations. "Our data suggest that patient stratification based on their tumour´s Cdh1 status could improve the effect of etoposide in these patients' treatment".

The next step for Malumbres' team is to study this new drug cocktail in patients and to investigate the tumours in which this new therapeutic strategy would be most effective.



INFORMATION:



This project has been funded by the Ministry of Economy and competitiveness, the European Union and the Community of Madrid.



ELSE PRESS RELEASES FROM THIS DATE:

U of T report finds millions of Canadians still struggle to afford food

2014-02-06
Four million Canadians, including 1.15 million children, are living in households where it is sometimes a struggle to put food on the table, according to researchers at the University ...

Fires in Victoria, Australia, Feb. 6, 2014

2014-02-06
Fires in and around Snowy River National Park in Victoria, Australia were captured by the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua satellite on February 06, 2014. Actively burning areas, detected ...

A microchip for metastasis

2014-02-06
Nearly 70 percent of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary ...

Fires in Northern Sumatra

2014-02-06
Fires dot the coast of Northern Sumatra, Indonesia, in this Moderate Resolution Imaging Spectroradiometer (MODIS) satellite image collected on February 06, 2014. The MODIS instrument is aboard the Terra satellite and actively burning ...

RNA sequencing of 750-year-old barley virus sheds new light on the Crusades

2014-02-06
Scientists have for the first time sequenced an ancient RNA genome – of a barley virus once believed to be only 150 years old - pushing its origin back at least 2,000 years and revealing how intense ...

Vanderbilt scientists contribute to finding that could lead to the first effective RSV vaccine

2014-02-06
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective ...

NASA sees Tropical Cyclone Edilson leaving Mauritius

2014-02-06
NASA's Terra satellite saw Tropical Cyclone Edilson pulling away from the island of Mauritius in the Southern Indian Ocean when it passed overhead on February 6, 2014. The Moderate Resolution Imaging Spectroradiometer ...

Heart health through gut health

2014-02-06
A new study, "Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets," published in the January issue of Nutrition ...

New investigational drug holds promise for combatting deadly mucormycosis infections

2014-02-06
LOS ANGELES – (Feb. 6, 2014) – With very few treatment options available ...

Quick test finds signs of diarrheal disease

2014-02-06
Bioengineers at Rice University and the University of Texas Medical Branch (UTMB) at Galveston have developed a simple, highly sensitive and efficient test for the diarrheal disease ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] CNIO researchers propose a new combined therapy to treat cancer
The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments